![](https://news.europawire.eu/wp-content/uploads/2016/08/SHIRE-LOGO-144x144.jpg)
New system reduces number of steps in the treatment process for hemophilia A patients on ADYNOVATE [Antihemophilic Factor, (Recombinant), PEGylated] LEXINGTON, Mass., 04-Aug-2016 — /EuropaWire/ — Shire plc (LSE: SHP, NASDAQ: SHPG) announced that the U.S. Food and Drug Administration (FDA) … Read the full press release